DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme
Cancer cells can resist the effects of DNA-damaging therapeutic agents via utilization of DNA repair pathways, suggesting that DNA repair capacity (DRC) measurements in cancer cells could be used to identify patients most likely to respond to treatment. However, the limitations of available technolo...
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
American Association for Cancer Research (AACR)
2016
|
Online Access: | http://hdl.handle.net/1721.1/105169 https://orcid.org/0000-0003-1787-046X https://orcid.org/0000-0002-7112-1454 |